Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update
- PMID: 17213346
- PMCID: PMC1860608
- DOI: 10.1136/jcp.2005.035592
Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update
Abstract
Diabetic nephropathy is a common cause of end-stage renal disease worldwide. It is characterised by diffuse or nodular glomerulosclerosis, afferent and efferent hyaline arteriolosclerosis, and tubulointerstitial fibrosis and atrophy. Diffuse and nodular diabetic glomerulosclerosis share similar histological features with other clinical conditions. Immunofluorescence and electron microscopy studies, and clinicopathological correlation are essential to differentiate diabetic nephropathy from other conditions that result in diffuse and nodular glomerulosclerosis.
Conflict of interest statement
Competing interests: None declared.
References
-
- Estacio R O, Schrier R W. Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression. Adv Int Med 200146359–408. - PubMed
-
- Parving H H. Diabetic nephropathy: prevention and treatment. Kidney Int 2001602041–2055. - PubMed
-
- Hostetter T H. Hyperfiltration and glomerulosclerosis. Semin Nephrol 200323194–199. - PubMed
-
- Wolf G, Butzmann U, Wenzel U O. The renin‐angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 2003933–13. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical